NanoBioRS-Continuous reporting R1-SOP for working with MC3T3 cell line

Scope

This document was created in order to facilitate knowledge transfer between the ER and the host institution (UIBK) as part of NanoBioRS-MSCA action. This is in line with data sharing as delineated in the data management plan of NanoBioRS (D2.1-ORDP-NanoBioRS).

The cell line MC3T3-E1 Subclone 4 (MC3T3-E1) acquired through NanoBioRS project was not previously available at the Drug Delivery and Powder Technology Group (DDPT-UIBK). The ER characterized this cell line and set up different techniques presented in this SOP. This encompasses the manipulation, characterization, preservation, and application of experimental techniques used to investigate drug delivery systems relevant to the project and their potential extensions beyond its current scope.

All the methods were applied on the frame of NanoBioRS and this SOP will be made public once the outcomes of the projects are published.